Behavioral characteristics reported at enrollment for 586 discordant couples with participants classified on the basis of ART use by the HIV positive participant during the study.

<p>Behavioral characteristics reported at enrollment for 586 discordant couples with participants classified on the basis of ART use by the HIV positive participant during the study.</p

Trends in HIV risk behaviour after couples counseling with participants stratified on the basis of gender.

<p>Note: N is number of participants who answered the specific questions. N reporting is number of participants whose answer is "yes" to the specific questions.</p

Demographic and clinical characteristics reported at enrollment for 586 discordant couples with participants classified on the basis of ART use by the HIV positive participant during the study.

<p>Demographic and clinical characteristics reported at enrollment for 586 discordant couples with participants classified on the basis of ART use by the HIV positive participant during the study.</p

Characteristics of couples where seroconversion occurred when HIV participant was receiving ART for more than 3 months.

<p>Notes:</p><p>¹ Adherence is a composite of two questions: “How often do you use miss taking your ARVs?” and “How many pills have you missed in the last week?”. If participant reported any response other than “never” and “0”, respectively, was reported as non-adherent</p><p>² Condom use is a composite of two questions: “How often do you use condoms?” and “Did you use a condom the last time you had sex?”. If participant reported any response other than “always” and “yes”, respectively, condom use is reported as inconsistent</p><p>³ VL result taken on the day of serconversion = 176 copies/ mL. Reported value of 235,789 copies/mL was prior to ART initiation, 6 months prior to seroconversion.</p><p>Characteristics of couples where seroconversion occurred when HIV participant was receiving ART for more than 3 months.</p

Study profile of the Highly Active Antiretroviral therapy as Prevention (HAARP) Study.

<p>Study profile of the Highly Active Antiretroviral therapy as Prevention (HAARP) Study.</p